Latest Australian Taxation News

Senetas Corporation has streamlined its operations following the sale of Votiro, reporting a strong financial position and unveiling plans for a significant capital return and share consolidation.

RocketBoots Limited has renewed its pivotal contract with a major Australian retailer, extending an eight-year partnership and securing upfront cash payments. The company also anticipates additional inflows from banking sector pilots and R&D tax incentives, underpinning its growth trajectory.

BlackRock Investment Management (Australia) Limited has announced confirmed cash distributions for three Australian iShares ETFs, with payments scheduled for 19 November 2025. Investors are reminded to update bank details and complete tax certifications ahead of the payment date.

State Gas Limited is on the cusp of securing its first 2P Reserve certification for the Rolleston West Project, while progressing its innovative High Density Natural Gas technology despite financial and operational hurdles.

TPG Telecom is set to return approximately $3 billion to shareholders through a capital reduction and special dividend, pending a final tax ruling from the Australian Taxation Office.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Careteq Limited signals progress on its 1-System platform integration with a planned Q3 FY26 restart, while Embedded Health Solutions expands aged care contracts and the company navigates a significant ATO R&D tax objection.

Wrkr Ltd has reported a strong start to FY26 with its third consecutive quarter of positive operating cash flow and a successful $15 million capital raise, positioning the fintech for accelerated growth ahead of major client launches.

Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.

Memphasys Limited has disclosed a $1.118 million liability linked to its FY24 R&D tax rebate following an ASX inquiry, while confirming compliance with continuous disclosure rules and ongoing engagement with the ATO for a private ruling.

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

Ryder Capital Limited has announced a 20% increase in its annual dividend, moving to quarterly payments starting January 2026, enhancing income certainty for shareholders.